UNIVERSITY OF CHICAGO – EDWARD NAURECKAS, MD
Supporting innovative pulmonary research focused on cystic fibrosis, bronchiectasis, NTM, asthma, and COPD through multidisciplinary collaboration, microbiome research, and clinical excellence.
Edward Naureckas, MD
Principal Investigator
University of Chicago
Institution
Airways Disease Research Program
Research & Clinical Program
Project Overview
Bronchiectasis is a chronic lung disease characterized by permanent dilation of the airways, often resulting from chronic nfections and inflammation. nontuberculous mycobacteria (NTM) are an important cause f bronchiectasis, yet the mechanisms by which NTM lead to airway damage remain poorly understood.
Project Summary
This study aims to investigate how NTM infection contributes to the progression advanced imaging, microbiological, and immunological techniques. Understanding these mechanisms may lead to better diagnostic tools and targeted therapies for patients with NTM-related bronchiectasis.
Project Goals
- To characterize the immune response in the lungs during NTM infection
- To identify bacterial and host factors associated with airway damage.
- To evaluate potential biomarkers for disease progression
Impact
This research will improve our understanding of NTM-related bronchiectasis and may help identify new strategies for earlier diagnosis and more effective treatments.
Advancing Research. Improving Lives.
Support innovative NTM research that drives better outcomes for patients.
Edward Naureckas, MD
Colin Swenson, P.I.: colin.swenson@emory.edu | (516) 455-6655 (cell)
Diana Beltran, CTM: djbeltr@emory.edu | (678) 848-0866 (cell)
Amrina Anwar, CRC: aanwar@emory.edu
Erin Barton, NP: erin.barton@emoryhealthcare.org
Cathy Munson, RN: catherine.munson@emoryhealthcare.org
Project Overview
The NTM Research Consortium funds early-stage research to accelerate advances in the diagnosis, treatment, and cure of NTM lung disease.